The second man earlier in this series had the clean-looking testosterone number and still had no libido. That is the pattern to keep in mind. But I want to start with a different fork, because it shows where a lot of men get pushed down the wrong road.

A man in his late 30s. Testosterone was low-normal. Not crashed. Not where he wanted it either. The easy move would have been replacement: see the number, prescribe to the number, move on.

We did not start there.

Two things mattered. His own upstream signals, the pituitary hormones that tell the testes to work, were still present. The factory was online. It was just running slow. And he wanted to keep fertility on the table.

That changes the question. You can raise testosterone by pouring the finished hormone in from outside. That works the number, but it also tells the body to stop making its own. Or you can push the system that makes testosterone and ask it to run harder. Same target number. Very different trade.

We chose the second road, a compounded oral that drives his own production upward. We will name it and unpack it fully in Part 4 of this series. For today, the drug is not the point. The principle is: if the factory still works, do not casually shut it down.

And pause there. Even if the hormone number improves, that still does not prove the man will want sex. That is a separate circuit.

The fine print. Everything named in this series — GLP-1 medications, PT-141, the axis-preserving oral, the vascular-repair peptides — is a prescription product, evaluated and dosed under physician supervision, and where compounded, dispensed by a licensed 503A pharmacy. Several are used off-label or are not FDA-approved finished products. Nothing here is a recommendation to start, stop, or change any medication on your own, and care is available only in select states.

~3 min with Dr. Gupta on why a “normal” testosterone number can still leave the lights off — and where to look instead.

If you’re skimming: A good testosterone number only proves the raw material exists. It doesn’t tell you whether the cascade above it is firing, whether estradiol is intact, or whether the brain’s wanting circuit is awake. Three separate questions — three separate fixes.

A good testosterone number answers one question. It does not answer the desire question.

Desire on the “want” side is not one switch. It is a cascade. The order matters.

At the top is kisspeptin, a brain signal that fires in pulses. That drives GnRH, which tells the pituitary to send LH and FSH into the blood. LH reaches the testes and says: make testosterone. FSH supports sperm production. Some testosterone then converts into estradiol. Yes, men need estradiol too, especially in the brain.

So the chain reads top to bottom:

Read it this way and the second man’s failure stops looking mysterious. His finished hormone looked fine. The cascade above it had not really been interrogated.

Kisspeptin also does something important beyond hormone production. It reaches into the brain’s emotional and sexual-processing centers. In a trial of men with low desire, it raised arousal response by 56% over placebo, and a 2025 breakthrough showed it can be delivered as a nasal spray. That makes it one of the most upstream levers in the field. It is still in clinical trials and not yet available. We are watching it, not prescribing it.

Testosterone also reports back up the chain. It tells the master switch, we have enough, ease off. That feedback loop is how the body keeps balance. It is also the trap.

When you pour testosterone in from outside, the body reads the high level and does what it is built to do. Kisspeptin quiets. LH drops. The testes stop getting the order. Own production falls, and sperm production can fall with it.

The number can look great while the factory behind it goes dark. For a man who wants fertility preserved, that is not a footnote. That is the decision.

That is why we did not reach for replacement in the late-30s case. There is an axis-preserving lever that blocks the “ease off” signal, so the body drives its own LH and testosterone up with the factory still running. That is the Part 4 payoff.

The other way the hormone layer gets broken is simpler: we break it.

When men go on testosterone, some of it converts to estradiol. A common reflex is to suppress that conversion with an aromatase inhibitor “to control estrogen.” Pushed too hard, estradiol crashes. The male brain needs estradiol for desire, mood, and even joint comfort. So now you have a man with a beautiful testosterone number who feels worse: flat libido, low mood, achy joints.

Estradiol is not a contaminant. The balance is the point.

Here is the part people miss. You can get every hormone right: testosterone reasonable, estradiol respected, the cascade intact. The lights can still be off.

Because wanting lives in a different circuit. The pull toward sex is generated by the brain’s melanocortin system, the MC4R pathway. That is the mechanism behind PT-141, the one tool we have aimed directly at “want” rather than hormones or blood flow. Around it sits the reward layer: dopamine, which drives wanting and anticipation, and oxytocin, which helps with bonding and satisfaction.

This is where SSRIs matter. They raise serotonin tone, and serotonin can dampen the dopamine reward circuit that desire runs on. That is not a rare quirk. It is the pharmacology doing what it does, pointed in the wrong direction for libido.

So the fork is simple. If the hormone substrate is low, fix it. If the desire circuit is quiet, pushing the testosterone number higher may miss the problem entirely.

Read the full dispatch →

A normal testosterone level does not mean the desire engine is working. The next question is: is the cascade running, is estradiol intact, and is the reward circuit awake? Next in this series: the “can” side, the plumbing everyone reaches for first, and why it can only amplify a signal it cannot create.

Kinetic Edge Health is a physician-led telehealth practice focused on longevity, metabolic optimization, and urological wellness. If a stack in this issue is relevant to you, book a strategy session — or see how we read the metabolic-hormonal system.

Short-form dispatches on longevity, metabolic health, and men's performance — from the founder of Kinetic Edge Health.

Physician-led telehealth medical practice. Licensed in select states. Content is educational and does not constitute medical advice. Peptides and compounded medications are prescription items requiring physician evaluation and ongoing clinical oversight.

Privacy · Terms · Telehealth Consent

kineticedgehealth.com · Cleveland, OH

© 2026 Kinetic Edge Health, Inc. · All rights reserved.